LPCN
Lipocine Inc.
Company overview
- Market capitalization
- $17.23M
- Employees
- 14
- Latest publication
- 2026-09-29
About Lipocine Inc.
Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. It also develops LPCN 1154 (BRLIZIO), an oral neuro-steroid in a Phase 3 pivotal trial for postpartum depression; LPCN 1148, a prodrug of testosterone and testosterone laurate that has completed a Phase 2 trial for the management of decompensated cirrhosis; LPCN 1107, an oral hydroxy progesterone caproate product that has completed a Phase 2 trial for the prevention of recurrent preterm birth; LPCN 1144, an oral prodrug of bioidentical testosterone that has completed a Phase 2 trial for pre-cirrhotic non-alcoholic steatohepatitis; and LPCN 2401, an oral formulation comprising a proprietary anabolic androgen receptor agonist that is in a Phase 2 trial to manage incretin mimetic use in obesity management. In addition, the company is developing LPCN 2201, an oral brexanolone formulation that has completed a Phase 1 trial for major depressive disorders; LPCN 2203, an oral candidate that has completed a Phase 1 trial for management of essential tremor; and LPCN 2101, a neuroactive steroids (NAS) candidate that has completed a Phase 1 trial for drug-resistant epilepsy and women with epilepsy. The company's products focus on neurological and psychiatric central nervous system (CNS) disorders, liver disease, and hormone supplementation in the United States. It has a collaboration with Verity Pharmaceuticals, Inc. to develop and commercialize TLANDO; and TLANDO XR (LPCN 1111), a once-daily oral product candidate that has completed a Phase 2 trial for testosterone replacement therapy. Lipocine Inc. was founded in 1997 and is headquartered in Salt Lake City, Utah.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q1 20242024-03-31 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 119,397USD | 1,145,390USD | 114,574USD | 93,864USD | 3,491,406USD | 7,617,174USD | 216,188USD | -3,121,996USD |
| Cost Of Revenue | 14,814USD | 14,981USD | — | 15,570USD | 15,571USD | 8,512USD | 8,003USD | 6,000,794USD |
| Gross Profit | 104,583USD | 1,130,409USD | 114,574USD | 93,864USD | 3,491,406USD | 7,617,174USD | 216,188USD | -3,121,996USD |
| Research Development | 2,749,580USD | 2,693,910USD | 2,707,777USD | 1,061,571USD | 1,072,872USD | 2,818,926USD | 1,674,932USD | 2,878,798USD |
| Selling General Administrative | 1,204,467USD | 983,390USD | 767,837USD | 1,122,477USD | 873,055USD | 1,575,719USD | 1,134,607USD | 1,042,572USD |
| Total Operating Expenses | 3,954,047USD | 3,646,210USD | 3,475,614USD | 2,184,048USD | 1,945,927USD | 4,394,645USD | 2,809,539USD | 3,921,370USD |
| Operating Income | -3,849,464USD | -2,515,801USD | -3,361,040USD | -2,090,184USD | 1,545,479USD | 3,222,529USD | -2,593,351USD | -7,043,366USD |
| Interest Income | 177,570USD | 145,717USD | 174,208USD | 225,511USD | 233,118USD | 331,364USD | 299,379USD | 317,569USD |
| Net Interest Income | 177,570USD | 145,717USD | 174,208USD | 225,511USD | 233,118USD | 331,364USD | 299,379USD | 317,569USD |
| Income Before Tax | -3,671,894USD | -2,370,084USD | -3,186,832USD | -1,864,673USD | 1,782,183USD | 3,513,821USD | -2,281,698USD | -6,650,970USD |
| Tax Provision | 0USD | 0USD | 0USD | 200USD | 0USD | 200USD | 555USD | 0USD |
| Net Income | -3,671,894USD | -2,370,084USD | -3,186,832USD | -1,864,873USD | 1,782,183USD | 3,513,621USD | -2,282,253USD | -6,650,970USD |
| Net Income From Continuing Ops | -3,671,894USD | -2,370,084USD | -3,186,832USD | -1,864,873USD | 1,782,183USD | 3,513,621USD | -2,282,253USD | -6,650,970USD |
| Ebit | -3,671,894USD | -2,370,084USD | -3,186,832USD | -1,864,673USD | 1,782,183USD | 3,513,821USD | -2,281,698USD | -6,650,970USD |
| Ebitda | -3,657,080USD | -2,357,088USD | -3,170,724USD | -1,849,103USD | 1,797,754USD | 3,522,333USD | -2,273,695USD | -6,643,222USD |
| Depreciation And Amortization | 14,814USD | 12,996USD | 16,108USD | 15,570USD | 15,571USD | 8,512USD | 8,003USD | 7,748USD |
| Reconciled Depreciation | 14,814USD | 14,981USD | 14,123USD | 15,570USD | 15,571USD | 8,512USD | 8,003USD | 7,748USD |
| Total Other Income Expense Net | 177,570USD | 145,717USD | 174,208USD | 225,511USD | 236,704USD | 291,292USD | 311,653USD | 392,396USD |
| Income Tax Expense | — | -400USD | — | 200USD | — | 200USD | 555USD | -7,748USD |
| Interest Expense | — | — | — | — | — | — | 400USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 11,198,144USD | -2,850,818USD | 16,140,838USD | 0USD | 428,031USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 41,106USD | 10,175,251USD | 7,665,559USD | 9,748,469USD | 6,464,708USD | 11,004,281USD | 8,076,053USD | 12,580,245USD |
| Gross Profit | 11,198,144USD | -13,026,069USD | 8,475,279USD | -9,748,469USD | 428,031USD | -11,004,281USD | -8,076,053USD | -12,580,245USD |
| Research Development | 7,351,753USD | 10,175,251USD | 7,665,559USD | 9,748,469USD | 6,464,708USD | 11,004,281USD | 8,076,053USD | 12,580,245USD |
| Selling General Administrative | 5,001,426USD | 4,904,888USD | 5,329,776USD | 8,247,795USD | 5,289,142USD | 10,213,695USD | 10,382,146USD | 5,801,823USD |
| Total Operating Expenses | 12,353,179USD | 4,904,888USD | 5,329,776USD | 17,996,264USD | 12,087,353USD | 20,982,160USD | 18,970,756USD | 18,382,068USD |
| Operating Income | -1,155,035USD | -17,930,957USD | 3,145,503USD | -17,996,264USD | -11,325,819USD | -21,217,976USD | -18,458,199USD | -18,382,068USD |
| Interest Income | 1,146,902USD | 1,364,719USD | 67,700USD | 75,650USD | — | — | — | — |
| Net Interest Income | 1,146,902USD | 1,364,719USD | -135,592USD | -310,968USD | — | — | — | — |
| Income Before Tax | 9,033USD | -16,351,327USD | -634,199USD | -20,964,619USD | -11,659,322USD | -20,982,160USD | -18,970,756USD | -18,208,178USD |
| Income Tax Expense | 681USD | 755USD | 200USD | 200USD | 700USD | 700USD | 752USD | 200USD |
| Tax Provision | 681USD | 681USD | 200USD | 200USD | 700USD | 700USD | 752USD | — |
| Net Income | 8,352USD | -16,352,082USD | -634,399USD | -20,964,819USD | -11,660,022USD | -20,982,860USD | -18,971,508USD | -18,208,378USD |
| Net Income From Continuing Ops | 8,352USD | -16,299,742USD | -634,399USD | -20,964,819USD | -11,660,022USD | -20,982,860USD | -18,971,508USD | -18,208,378USD |
| Ebit | 9,033USD | -16,351,327USD | -430,907USD | -17,996,264USD | -11,325,819USD | -21,217,976USD | -18,970,754USD | -18,382,068USD |
| Ebitda | 50,139USD | -16,322,666USD | -430,527USD | -17,992,710USD | -11,307,224USD | -21,189,606USD | -18,938,794USD | -18,355,347USD |
| Depreciation And Amortization | 41,106USD | 28,661USD | 380USD | 3,554USD | 18,595USD | 28,370USD | 31,960USD | 26,721USD |
| Reconciled Depreciation | 41,106USD | 23,236USD | 380USD | 3,554USD | 18,595USD | 28,370USD | — | — |
| Total Other Income Expense Net | 1,164,068USD | 1,579,630USD | -3,779,702USD | -2,968,355USD | -333,503USD | 235,816USD | 216,078USD | 173,890USD |
| Unclassified Operating Expenses | — | -10,175,251USD | -7,665,559USD | — | — | — | — | — |
| Interest Expense | — | 0USD | 203,292USD | 386,618USD | 0USD | 0USD | 0USD | 0USD |
| Non Operating Income Net Other | — | — | -3,779,702USD | -2,968,355USD | -333,503USD | — | — | — |
| Net Income Applicable To Common Shares | — | — | -634,399USD | -20,964,819USD | -11,660,022USD | -20,982,860USD | -18,971,508USD | -18,208,378USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 25,358,166USD | 17,005,612USD | 16,073,167USD | 18,577,193USD | 20,499,726USD | 22,510,501USD | 20,698,318USD | 23,032,306USD |
| Other Current Assets | 404,452USD | 1,932,990USD | 683,797USD | 362,629USD | 428,795USD | 567,915USD | 588,824USD | 297,051USD |
| Total Liab | 2,527,843USD | 2,528,196USD | 1,931,119USD | 1,448,773USD | 1,299,649USD | 1,512,936USD | 1,581,218USD | 1,823,943USD |
| Total Stockholder Equity | 22,830,323USD | 14,477,416USD | 14,142,048USD | 17,128,420USD | 19,200,077USD | 20,997,565USD | 19,117,100USD | 21,208,363USD |
| Other Current Liab | 645,115USD | 1,106,783USD | 912,467USD | 685,779USD | 619,410USD | 921,240USD | 1,295,871USD | 1,375,145USD |
| Common Stock | 9,076USD | 8,944USD | 8,870USD | 8,865USD | 8,863USD | 8,863USD | 8,863USD | 8,863USD |
| Capital Stock | 9,076USD | 8,944USD | 8,870USD | 8,865USD | 8,863USD | 8,863USD | 8,863USD | 8,863USD |
| Retained Earnings | -213,068,261USD | -209,396,367USD | -207,026,283USD | -203,839,451USD | -201,633,735USD | -199,768,862USD | -201,551,045USD | -199,332,227USD |
| Cash | 5,015,608USD | 5,205,842USD | 3,901,040USD | 6,043,980USD | 3,354,596USD | 6,205,926USD | 3,742,941USD | 5,553,371USD |
| Cash And Short Term Investments | 24,729,071USD | 14,930,387USD | 15,131,071USD | 17,935,682USD | 19,718,646USD | 21,633,311USD | 19,823,632USD | 22,548,795USD |
| Total Current Assets | 25,244,934USD | 16,877,566USD | 15,930,140USD | 18,420,043USD | 20,326,468USD | 22,321,673USD | 20,503,938USD | 22,909,482USD |
| Total Current Liabilities | 2,527,843USD | 2,528,196USD | 1,931,119USD | 1,448,773USD | 1,299,649USD | 1,512,936USD | 1,581,218USD | 1,823,943USD |
| Current Deferred Revenue | 320,000USD | 320,000USD | 320,000USD | 320,000USD | 320,000USD | 320,000USD | — | — |
| Net Debt | -5,015,608USD | -4,756,251USD | -3,743,840USD | -6,043,980USD | -3,354,596USD | -6,205,926USD | -3,742,941USD | -5,553,371USD |
| Short Term Investments | 19,713,463USD | 9,724,545USD | 11,230,031USD | 11,891,702USD | 16,364,050USD | 15,427,385USD | 16,080,691USD | 16,995,424USD |
| Net Receivables | 111,411USD | 14,189USD | 115,272USD | 121,732USD | 179,027USD | 120,447USD | 91,482USD | 63,636USD |
| Accounts Payable | 1,562,728USD | 971,822USD | 861,452USD | 442,994USD | 360,239USD | 271,696USD | 285,347USD | 448,798USD |
| Property Plant Equipment Net | 89,479USD | 104,293USD | 119,274USD | 133,397USD | 149,505USD | 165,075USD | 170,627USD | 99,071USD |
| Property Plant Equipment Gross | 1,388,372USD | 1,388,372USD | 1,388,372USD | 1,388,372USD | 1,388,372USD | 1,388,372USD | 1,378,353USD | 1,298,286USD |
| Accumulated Other Comprehensive Income | -7,194USD | 4,445USD | 4,627USD | -1,243USD | 5,521USD | 9,138USD | 9,942USD | -9,719USD |
| Common Stock Shares Outstanding | 6,795,000shares | 5,708,238shares | 5,413,149shares | 5,351,957shares | 5,348,557shares | 5,422,604shares | 5,347,940shares | 5,343,922shares |
| Non Current Assets Total | 113,232USD | 128,046USD | 143,027USD | 157,150USD | 173,258USD | 188,828USD | 194,380USD | 122,824USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | 23,753USD | 23,753USD | 23,753USD | 23,753USD | 23,753USD | 23,753USD | 23,753USD | 23,753USD |
| Net Working Capital | 22,717,091USD | 14,349,370USD | 13,999,021USD | 16,971,270USD | 19,026,819USD | 20,808,737USD | 18,922,720USD | 21,085,539USD |
| Unclassified Equity | 235,887,626USD | 223,851,450USD | 221,145,964USD | 220,951,384USD | 220,810,565USD | 220,739,563USD | 220,640,477USD | 220,532,583USD |
| Short Term Debt | — | 449,591USD | 157,200USD | 251,519USD | — | 438,625USD | 153,365USD | — |
| Short Long Term Debt Total | — | 449,591USD | 157,200USD | 251,519USD | — | 438,625USD | 153,365USD | — |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 17,005,612USD | 22,510,501USD | 23,001,072USD | 37,542,922USD | 52,482,439USD | 25,352,776USD | 19,658,280USD | 20,851,953USD |
| Other Current Assets | 1,932,990USD | 567,915USD | 773,424USD | 945,319USD | 1,514,465USD | 5,661,258USD | 545,887USD | 5,520,113USD |
| Total Liab | 2,528,196USD | 1,512,936USD | 2,631,629USD | 1,907,982USD | 6,912,421USD | 10,010,857USD | 13,370,484USD | 11,418,280USD |
| Total Stockholder Equity | 14,477,416USD | 20,997,565USD | 20,369,443USD | 35,634,940USD | 45,570,018USD | 15,341,919USD | 6,287,796USD | 9,433,673USD |
| Other Current Liab | 1,106,783USD | 921,240USD | 1,235,652USD | 1,077,738USD | 2,016,458USD | 1,653,178USD | 449,303USD | 487,135USD |
| Common Stock | 8,944USD | 8,863USD | 8,860USD | 8,852USD | 8,830USD | 7,005USD | 3,766USD | 2,174USD |
| Capital Stock | 8,944USD | 8,863USD | 8,860USD | 8,852USD | 8,830USD | 7,005USD | 3,766USD | 2,174USD |
| Retained Earnings | -209,396,367USD | -199,768,862USD | -199,777,214USD | -183,425,043USD | -172,666,407USD | -172,032,008USD | -151,067,189USD | -138,059,845USD |
| Cash | 5,205,842USD | 6,205,926USD | 4,771,758USD | 3,148,496USD | 2,950,552USD | 19,217,382USD | 9,728,523USD | 8,077,539USD |
| Cash And Short Term Investments | 14,930,387USD | 21,633,311USD | 22,035,546USD | 32,529,906USD | 44,617,957USD | 19,667,374USD | 14,068,564USD | 15,250,576USD |
| Total Current Assets | 16,877,566USD | 22,321,673USD | 22,861,224USD | 34,135,080USD | 46,379,675USD | 25,329,023USD | 19,630,973USD | 20,809,203USD |
| Total Current Liabilities | 2,528,196USD | 1,512,936USD | 2,631,629USD | 1,678,126USD | 5,616,625USD | 6,583,731USD | 4,964,877USD | 4,491,748USD |
| Current Deferred Revenue | 320,000USD | 320,000USD | — | — | 1,016,458USD | — | — | — |
| Net Debt | -4,756,251USD | -6,205,926USD | -4,771,758USD | -3,148,496USD | -639,727USD | -13,626,974USD | -2,580,783USD | 2,182,326USD |
| Short Term Debt | 449,591USD | 438,625USD | 17,166USD | — | 2,310,825USD | 3,333,333USD | 3,333,333USD | 3,333,333USD |
| Short Long Term Debt Total | 449,591USD | 438,625USD | 17,166USD | — | 2,310,825USD | 5,590,408USD | 7,147,743USD | 10,259,865USD |
| Short Term Investments | 9,724,545USD | 15,427,385USD | 17,263,788USD | 29,381,410USD | 41,667,405USD | 449,992USD | 4,340,041USD | 7,173,037USD |
| Net Receivables | 14,189USD | 120,447USD | 52,254USD | 659,855USD | 247,253USD | 391USD | 16,522USD | 38,514USD |
| Accounts Payable | 971,822USD | 271,696USD | 1,395,977USD | 600,388USD | 1,289,342USD | 1,597,220USD | 1,182,241USD | 671,280USD |
| Property Plant Equipment Net | 104,293USD | 165,075USD | 116,095USD | 131,589USD | 7,211USD | 0USD | 3,554USD | 18,997USD |
| Property Plant Equipment Gross | 1,388,372USD | 1,388,372USD | 1,298,286USD | 1,285,119USD | 1,151,288USD | 1,143,697USD | 3,554USD | 18,997USD |
| Accumulated Other Comprehensive Income | 4,445USD | 9,138USD | 7,259USD | -20,321USD | -18,016USD | 0USD | -38USD | -963USD |
| Common Stock Shares Outstanding | 5,708,238shares | 5,422,604shares | 5,269,671shares | 5,256,169shares | 5,154,318shares | 3,275,768shares | 1,522,486shares | 1,256,019shares |
| Non Current Assets Total | 128,046USD | 188,828USD | 139,848USD | 3,407,842USD | 6,102,764USD | 23,753USD | 27,307USD | 42,750USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 229,856USD | 1,295,796USD | 3,427,126USD | 8,405,607USD | 6,926,532USD |
| Non Currrent Assets Other | 23,753USD | 23,753USD | 23,753USD | 23,753USD | 4,073,753USD | 23,753USD | 23,753USD | 23,753USD |
| Net Working Capital | 14,349,370USD | 20,808,737USD | 20,229,595USD | 32,456,954USD | 40,763,050USD | 18,745,292USD | 14,666,096USD | 16,317,455USD |
| Unclassified Equity | 223,851,450USD | 220,739,563USD | 220,121,678USD | 219,062,600USD | 218,277,493USD | 187,400,629USD | 157,388,203USD | 147,530,845USD |
| Other Liab | — | — | — | 229,856USD | 1,295,796USD | 1,170,051USD | 4,591,200USD | — |
| Other Assets | — | — | — | 3,276,253USD | 4,073,753USD | 23,753USD | 23,753USD | 23,753USD |
| Long Term Investments | — | — | — | 0USD | 2,021,800USD | 0USD | — | — |
| Inventory | — | — | — | 1USD | -41,914,658USD | 5,000,000USD | 5,000,000USD | — |
| Net Tangible Assets | — | — | — | 35,634,940USD | 45,570,018USD | 15,341,919USD | 6,287,796USD | 9,433,673USD |
| Short Long Term Debt | — | — | — | — | 2,310,825USD | 3,333,333USD | 3,333,333USD | 3,333,333USD |
| Treasury Stock | — | — | — | — | -40,712USD | -40,712USD | -40,712USD | -40,712USD |
| Non Current Liabilities Other | — | — | — | — | 1,295,796USD | — | — | — |
| Unclassified Non Current Assets | — | — | — | — | -4,073,753USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | -3,327,283USD | -3,333,333USD | -3,333,333USD | -3,333,333USD |
| Unclassified Non Current Liabilities | — | — | — | — | -1,295,796USD | — | — | — |
| Long Term Debt | — | — | — | — | — | 2,257,075USD | 3,814,407USD | 6,926,532USD |
| Unclassified Current Assets | — | — | — | — | — | -5,000,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,671,894USD | -2,370,084USD | -3,186,832USD | -2,205,716USD | -1,864,873USD | 1,782,183USD | -2,218,818USD | -3,068,634USD |
| Depreciation | 14,814USD | 14,981USD | 14,123USD | 16,108USD | 15,570USD | 15,571USD | 8,511USD | 8,512USD |
| Stock Based Compensation | 65,398USD | 53,032USD | 53,256USD | 65,205USD | 71,002USD | 99,086USD | 107,894USD | 102,265USD |
| Other Non Cash Items | -96,418USD | -66,403USD | -33,908USD | -34,416USD | -58,209USD | -122,161USD | -306,227USD | -111,819USD |
| Change To Account Receivables | 928,771USD | 101,083USD | 6,460USD | 57,295USD | -58,580USD | -28,965USD | -27,846USD | 36,498USD |
| Change In Working Capital | 1,430,963USD | -551,033USD | 167,638USD | 272,585USD | -132,747USD | -72,752USD | -424,262USD | 571,899USD |
| Total Cash From Operating Activities | -2,257,137USD | -2,919,507USD | -2,985,723USD | -1,886,234USD | -1,969,257USD | 1,701,927USD | -2,832,902USD | -2,497,777USD |
| Capital Expenditures | -3USD | -3USD | -3USD | -4USD | -3USD | -10,019USD | -80,067USD | -3USD |
| Free Cash Flow | -2,257,140USD | -2,919,510USD | -2,985,720USD | -1,886,230USD | -1,969,260USD | 1,691,908USD | -2,912,969USD | -2,497,780USD |
| Investments | -9,904,139USD | 1,571,709USD | 701,449USD | 4,500,000USD | -882,073USD | 761,058USD | 1,022,472USD | 4,752,371USD |
| Total Cashflows From Investing Activities | -9,904,139USD | 1,571,709USD | 701,449USD | 4,500,000USD | -882,073USD | 761,058USD | 1,022,472USD | 4,752,371USD |
| Total Cash From Financing Activities | 11,971,042USD | 2,652,600USD | 141,334USD | 75,618USD | 0USD | 0USD | 0USD | 217,440USD |
| Issuance Of Capital Stock | 11,964,056USD | 2,652,600USD | 141,334USD | 75,618USD | 0USD | 0USD | 0USD | — |
| Change In Cash | -190,234USD | 1,304,802USD | -2,142,940USD | 2,689,384USD | -2,851,330USD | 2,462,985USD | -1,810,430USD | 2,472,034USD |
| Begin Period Cash Flow | 5,205,842USD | 3,901,040USD | 6,043,980USD | 3,354,596USD | 6,205,926USD | 3,742,941USD | 5,553,371USD | 3,081,337USD |
| End Period Cash Flow | 5,015,608USD | 5,205,842USD | 3,901,040USD | 6,043,980USD | 3,354,596USD | 6,205,926USD | 3,742,941USD | 5,553,371USD |
| Other Cashflows From Financing Activities | — | 2,652,600USD | 141,334USD | 75,618USD | — | — | -209,340USD | 217,440USD |
| Unclassified Financing Cash Flow | — | -2,652,600USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | -4USD | 4,752,371USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -4,752,368USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -9,627,505USD | 8,352USD | -16,352,082USD | -10,758,636USD | -634,399USD | -20,964,819USD | -13,007,344USD | -11,660,022USD |
| Depreciation | 60,782USD | 41,106USD | 28,661USD | 9,453USD | 380USD | 3,554USD | 15,443USD | 18,595USD |
| Stock Based Compensation | 242,497USD | 408,551USD | 654,438USD | 636,140USD | 603,946USD | 1,373,182USD | 1,035,834USD | 1,457,720USD |
| Other Non Cash Items | -192,938USD | -715,031USD | 1,795,464USD | -932,146USD | 53,750USD | 2,764,106USD | -179,497USD | 259,865USD |
| Change To Account Receivables | 106,258USD | -68,193USD | 738,106USD | 384,898USD | -246,862USD | 16,131USD | 21,992USD | 3,304,480USD |
| Change In Working Capital | -243,557USD | -964,211USD | 2,007,528USD | -923,630USD | -4,594,667USD | 1,520,879USD | 469,347USD | -1,994,117USD |
| Total Cash From Operating Activities | -9,760,721USD | -1,221,233USD | -11,865,991USD | -11,968,819USD | -4,411,303USD | -15,303,098USD | -11,666,217USD | -12,078,825USD |
| Capital Expenditures | -1USD | -90,086USD | -13,167USD | -133,831USD | -7,591USD | -7,591USD | -7,591USD | -7,591USD |
| Free Cash Flow | -9,760,720USD | -1,311,319USD | -11,879,158USD | -12,102,650USD | -4,418,894USD | -15,303,098USD | -11,666,217USD | -12,078,825USD |
| Investments | 5,891,085USD | 2,446,061USD | 12,954,380USD | 14,293,707USD | -43,772,806USD | 3,892,703USD | 2,998,227USD | 11,286,281USD |
| Total Cashflows From Investing Activities | 5,891,085USD | 2,446,061USD | 13,084,686USD | 14,293,707USD | -43,780,397USD | 3,892,703USD | 2,998,227USD | 11,293,281USD |
| Total Cash From Financing Activities | 2,869,552USD | 209,340USD | 404,567USD | -2,126,944USD | 26,924,870USD | 20,899,254USD | 10,318,974USD | 10,652,334USD |
| Issuance Of Capital Stock | 2,869,552USD | 209,340USD | 404,567USD | -5,130USD | 30,246,510USD | 14,657,508USD | 13,595,953USD | 652,334USD |
| Change In Cash | -1,000,084USD | 1,434,168USD | 1,623,262USD | 197,944USD | -21,266,830USD | 9,488,859USD | 1,650,984USD | 9,866,790USD |
| Begin Period Cash Flow | 6,205,926USD | 4,771,758USD | 3,148,496USD | 2,950,552USD | 24,217,382USD | 14,728,523USD | 13,077,539USD | 3,210,749USD |
| End Period Cash Flow | 5,205,842USD | 6,205,926USD | 4,771,758USD | 3,148,496USD | 2,950,552USD | 24,217,382USD | 14,728,523USD | 13,077,539USD |
| Other Cashflows From Financing Activities | 2,869,552USD | 209,340USD | 13,084,686USD | 211,423USD | 11,693USD | 7,674,876USD | 56,355USD | 10,000,000USD |
| Unclassified Financing Cash Flow | -2,869,552USD | — | -13,084,686USD | — | 3,394,360USD | 1,329,492USD | — | -10,000,000USD |
| Net Borrowings | — | — | 0USD | -2,316,667USD | -3,333,333USD | -1,433,130USD | -3,333,334USD | 10,000,000USD |
| Change To Inventory | — | — | — | -384,898USD | 246,862USD | -16,131USD | -21,992USD | — |
| Change To Liabilities | — | — | — | -688,954USD | -944,598USD | 1,620,119USD | 473,129USD | -936,711USD |
| Dividends Paid | — | — | — | -211,423USD | — | — | — | — |
| Sale Purchase Of Stock | — | — | — | -21,700USD | 26,852,150USD | 13,328,016USD | 13,652,153USD | 652,334USD |
| Other Cashflows From Investing Activities | — | — | — | 14,293,707USD | -43,780,397,000USD | 3,892,703USD | 2,998,227USD | 7,000USD |
| Unclassified Investing Cash Flow | — | — | — | -14,159,876USD | 43,780,397,000USD | -3,885,112USD | -2,990,636USD | — |
| Cash And Cash Equivalents Changes | — | — | — | — | -21,266,830USD | 9,488,859USD | 1,650,984USD | 9,866,790USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Product | License | 1,500,000 | USD | 0001493152-26-009411 |
| FY 2025Yearly · 2025-12-31 | Product | Royalty | 476,677 | USD | 0001493152-26-009411 |
| FY 2024Yearly · 2024-12-31 | Product | License | 10,900,000 | USD | 0001493152-26-009411 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 298,144 | USD | 0001493152-26-009411 |
| FY 2021Yearly · 2021-12-31 | Product | License | 11,000,000 | USD | 0001493152-23-007178 |
| FY 2021Yearly · 2021-12-31 | Product | Materials | 1,035,844 | USD | 0001493152-23-007178 |
| FY 2021Yearly · 2021-12-31 | Product | Minimum Guaranteed Royalties | 4,050,000 | USD | 0001493152-23-007178 |
| FY 2021Yearly · 2021-12-31 | Product | Sales Based Royalties | 54,994 | USD | 0001493152-23-007178 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.